Johnson & Johnson Executive Says Vaccine Works Where It Counts: Preventing Deaths

Content Curator
The Johnson & Johnson COVID-19 vaccine, pictured in December, is 66% effective at preventing moderate and severe disease. But Dr. Paul Stoffels of Johnson & Johnson says what matters more is preventing hospitalizations and deaths, which it did completely.

Dr. Paul Stoffels, the chief scientific officer at Johnson & Johnson, tells NPR the company's vaccine is very effective where it matters most: preventing hospitalizations and deaths.

(Image credit: Michael Ciaglo/Getty Images)